These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL; Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996 [TBL] [Abstract][Full Text] [Related]
23. [Inhaled insulin, new perspective for insulin therapy]. Radermecker RP; Sélam JL Rev Med Liege; 2005; 60(5-6):355-60. PubMed ID: 16035294 [TBL] [Abstract][Full Text] [Related]
24. Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients. Brunner GA; Balent B; Ellmerer M; Schaupp L; Siebenhofer A; Jendle JH; Okikawa J; Pieber TR Diabetologia; 2001 Mar; 44(3):305-8. PubMed ID: 11317660 [TBL] [Abstract][Full Text] [Related]
25. Newer devices and improved formulations of inhaled insulin. Rashid J; Absar S; Nahar K; Gupta N; Ahsan F Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886 [TBL] [Abstract][Full Text] [Related]
26. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung. Patton JS Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136 [TBL] [Abstract][Full Text] [Related]
27. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy. Scherbaum WA Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137 [TBL] [Abstract][Full Text] [Related]
28. Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera. Al-Tabakha MM J Control Release; 2015 Oct; 215():25-38. PubMed ID: 26222134 [TBL] [Abstract][Full Text] [Related]
29. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258 [TBL] [Abstract][Full Text] [Related]
30. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes. Rosenstock J; Cefalu WT; Hollander PA; Belanger A; Eliaschewitz FG; Gross JL; Klioze SS; St Aubin LB; Foyt H; Ogawa M; Duggan WT Diabetes Care; 2008 Sep; 31(9):1723-8. PubMed ID: 18535196 [TBL] [Abstract][Full Text] [Related]
31. Inhaled human insulin: an inspiration for patients with diabetes mellitus? Davidson MB; Mehta AE; Siraj ES Cleve Clin J Med; 2006 Jun; 73(6):569-78. PubMed ID: 16784157 [TBL] [Abstract][Full Text] [Related]
32. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes. Ellis SL; Gemperline KA; Garg SK Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of inhaled insulin therapy for diabetes mellitus. Siddiqui NI Mymensingh Med J; 2007 Jul; 16(2):237-45. PubMed ID: 17703168 [TBL] [Abstract][Full Text] [Related]